(Q35040745)

6 August 2017

Recent progress in ankylosing spondylitis treatment (English)

1 reference

6 August 2017

ankylosing spondylitis

1 reference

2

Daniel Wendling

1 reference

6 August 2017

Eric Toussirot

1

1 reference

PubMed ID

12517239

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

1 reference

6 August 2017

4

1 reference

6 August 2017

1

1 reference

6 August 2017

1-12

1 reference

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

6 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

The outcome of ankylosing spondylitis: a study of 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Second-line treatment in seronegative spondylarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Methotrexate in the treatment of ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

One-year open-label trial of thalidomide in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.1

21 January 2018

Identifiers

DOI

10.1517/14656566.4.1.1

1 reference

6 August 2017

1 reference

PubMed ID

12517239